Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Gale

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Blood|June 5, 2004
Activated protein C variants with normal cytoprotective but reduced anticoagulant activityLaurent O Mosnier, Andrew J Gale, Subramanian Yegneswaran, et al.
Thrombosis and Haemostasis|January 10, 2009
Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein CSubramanian Yegneswaran, Phuong M Nguyen, Andrew J Gale, et al.
Thrombosis and Haemostasis|December 15, 2012
Platelet protein S directly inhibits procoagulant activity on platelets and microparticlesFabian Stavenuiter, Nicole F Davis, Erning Duan, et al.
The Journal of Biological Chemistry|June 8, 2007
Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage siteAndrew J Gale, Subramanian Yegneswaran, Xiao Xu, et al.
Protein Science : a Publication of the Protein Society|August 23, 2002
Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein CAndrew J Gale, Xiao Xu, Jean-Luc Pellequer, et al.
Thrombosis and Haemostasis|October 16, 2015
Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIaVikas Bhat, Annette von Drygalski, Andrew J Gale, et al.
Thrombosis Research|May 14, 2016
Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosisAbdulrahman Alsultan, Andrew J Gale, Kadijah Kurban, et al.
The Journal of Biological Chemistry|July 25, 2007
Factor Va residues 311-325 represent an activated protein C binding regionSubramanian Yegneswaran, Yumi Kojima, Phuong M Nguyen, et al.
Chembiochem : a European Journal of Chemical Biology|January 22, 2009
Heparin antagonism by polyvalent display of cationic motifs on virus-like particlesAndrew K Udit, Chris Everett, Andrew J Gale, et al.
Pharmaceutical Research|March 11, 2016
Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe BleedingAndrew J Gale, Vikas Bhat, Jean-Luc Pellequer, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Blood|June 5, 2004
Activated protein C variants with normal cytoprotective but reduced anticoagulant activityLaurent O Mosnier, Andrew J Gale, Subramanian Yegneswaran, et al.
Thrombosis and Haemostasis|January 10, 2009
Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein CSubramanian Yegneswaran, Phuong M Nguyen, Andrew J Gale, et al.
Thrombosis and Haemostasis|December 15, 2012
Platelet protein S directly inhibits procoagulant activity on platelets and microparticlesFabian Stavenuiter, Nicole F Davis, Erning Duan, et al.
The Journal of Biological Chemistry|June 8, 2007
Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage siteAndrew J Gale, Subramanian Yegneswaran, Xiao Xu, et al.
Protein Science : a Publication of the Protein Society|August 23, 2002
Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein CAndrew J Gale, Xiao Xu, Jean-Luc Pellequer, et al.
Thrombosis and Haemostasis|October 16, 2015
Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIaVikas Bhat, Annette von Drygalski, Andrew J Gale, et al.
Thrombosis Research|May 14, 2016
Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosisAbdulrahman Alsultan, Andrew J Gale, Kadijah Kurban, et al.
The Journal of Biological Chemistry|July 25, 2007
Factor Va residues 311-325 represent an activated protein C binding regionSubramanian Yegneswaran, Yumi Kojima, Phuong M Nguyen, et al.
Chembiochem : a European Journal of Chemical Biology|January 22, 2009
Heparin antagonism by polyvalent display of cationic motifs on virus-like particlesAndrew K Udit, Chris Everett, Andrew J Gale, et al.
Pharmaceutical Research|March 11, 2016
Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe BleedingAndrew J Gale, Vikas Bhat, Jean-Luc Pellequer, et al.
Pageof 3